SCHEMBL25857063

SCHEMBL25857063

Cc1ccc2nc(-c3ccc(NC(C)C)c(N)c3)oc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.56
RAB9A P51151 12/20 0.56
ALDH1A1 P00352 10/20 0.56
SMN1; SMN2 Q16637 10/20 0.56
KDM4E B2RXH2 9/20 0.56
MAPT P10636 8/20 0.56
HPGD P15428 7/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
TDP1 Q9NUW8 1/20 0.56
HSD17B10 Q99714 6/20 0.49
NFKB1 P19838 3/20 0.49
NFKB2 Q00653 3/20 0.49
RELA Q04206 3/20 0.49
ATM Q13315 1/20 0.49
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP8 P22894 1/20 0.48
MMP13 P45452 1/20 0.48
TP53 P04637 5/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2688443 0.85 NPC1 (0.54) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL25857070 0.85 APP (0.53) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL2244364 0.80 RAB9A (0.67) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL25857069 0.78 ALDH1A1 (0.48) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23558137 0.77 NPC1 (0.44) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL25857064 0.77 NPC1 (0.45) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL12408905 0.77 NPC1 (0.84) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL5835023 0.76 ALOX5 (0.62) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL2247430 0.76 NPC1 (0.77) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23558405 0.75 ALDH1A1 (0.54) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 NPC1 301/4885RAB9A 3056/4885ALDH1A1 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.